One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:17
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
2023-11-01 07:21
John Paulson’s $1 Billion Caribbean Empire Faces Betrayal
In the decade since hedge fund billionaire John Paulson took a grand gamble on Puerto Rico, he’s faced
2023-10-21 02:56
Analysis-FTC settlement could shelter Amgen from US price cuts, taxes
By Deena Beasley The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics
2023-09-05 18:17
Amgen settles with the FTC over $28 billion deal
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September.
2023-09-02 00:29
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
By Manas Mishra and David Shepardson (Reuters) -The U.S. Federal Trade Commission has allowed Amgen to go ahead with its
2023-09-01 22:54
Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge
Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover of Horizon Therapeutics Plc
2023-08-29 01:47
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics,
2023-08-26 23:51
California, other states join FTC bid to block Amgen deal
The states of California, Minnesota and Wisconsin on Thursday joined a Federal Trade Commission lawsuit to stop Amgen's
2023-06-23 04:59
Popular Hedge-Fund Trade Draws Fresh Scrutiny as Debt Battle Rages On
A highly leveraged bond trade that’s become popular with hedge funds is drawing fresh scrutiny three years after
2023-05-26 19:52
FTC effort to stop Amgen's Horizon takeover faces uphill fight
By Diane Bartz WASHINGTON The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen
2023-05-18 23:20
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:28